Mereo BioPharma Group plc (MPH.L) (LON:MPH – Get Free Report) was down 1.9% during trading on Monday . The stock traded as low as GBX 26 ($0.33) and last traded at GBX 26.50 ($0.34). Approximately 49,264 shares traded hands during trading, a decline of 85% from the average daily volume of 333,975 shares. The stock had previously closed at GBX 27 ($0.35).
Mereo BioPharma Group plc (MPH.L) Stock Performance
The stock has a market cap of £89.76 million and a P/E ratio of -0.21. The company has a fifty day moving average price of GBX 26.50 and a 200 day moving average price of GBX 26.50. The company has a debt-to-equity ratio of 164.26, a current ratio of 2.98 and a quick ratio of 2.92.
About Mereo BioPharma Group plc (MPH.L)
Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor.
Read More
- Five stocks we like better than Mereo BioPharma Group plc (MPH.L)
- How to Use Stock Screeners to Find Stocks
- Don’t Miss These Stock Picks for the Lumber Price Surge
- What Are Dividend Challengers?
- NVIDIA Stock Defies Skeptics, Earns Analyst Upgrade
- About the Markup Calculator
- 3 Highly Profitable Companies Set for Double-Digit Upside
Receive News & Ratings for Mereo BioPharma Group plc (MPH.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mereo BioPharma Group plc (MPH.L) and related companies with MarketBeat.com's FREE daily email newsletter.
